Trials / Completed
CompletedNCT06092073
Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair
Efficacy and Safety of Bilateral Recto-Intercostal Fascial Plane Block on Perioperative Analgesia in Epigastric Hernia Repair : A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy and safety bilateral recto-intercostal fascial plane block (RIFPB) in epigastric hernia.
Detailed description
Epigastric hernias are usually occult in obese patients, and their symptoms may mimic peptic ulcer or gallbladder disease . Hernia repair is associated with considerable postoperative pain. The recto-intercostal fascial plane block (RIFPB) is a new novel approach that was developed by Tulgar et al., 2023 who hypothesized that when we inject a local anesthetic into the interfacial plane just inferolateral to the xiphoid, between the rectus abdominis muscle and the 6-7th costal cartilages (hence, between the cartilages and the intercostal muscles between them), blockade of the anterior branches of the nerves passing through this area can be guaranteed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | recto-intercostal fascial plane block | Patients will receive bilateral recto-intercostal fascial plane block using 20 mL of bupivacaine 0.25% on each side. |
| DRUG | bupivacaine | bupivacaine 0.25% |
Timeline
- Start date
- 2023-10-21
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2023-10-23
- Last updated
- 2026-01-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06092073. Inclusion in this directory is not an endorsement.